{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-127644","form_type":"8-K","ticker":"CRBP","cik":"0001595097","company_name":"Corbus Pharmaceuticals Holdings, Inc.","filed_at":"2024-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.912581+00:00","generated_at":"2026-05-29T23:46:44.157517+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Board member Anne Altmeyer adopts 10b5-1 plan to sell up to 2,452 shares of CRBP common stock","bullets":["Anne Altmeyer, Ph.D., board member, adopted Rule 10b5-1 plan on Nov 14, 2024.","Plan allows sale of up to 2,452 shares of common stock.","Sales may begin on February 13, 2025; plan terminates December 31, 2025.","Plan is intended to satisfy affirmative defense under Rule 10b5-1(c)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-127644","json":"https://secwatch.observer/filing/0000950170-24-127644.json","markdown":"https://secwatch.observer/filing/0000950170-24-127644.md","text":"https://secwatch.observer/filing/0000950170-24-127644.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024127644/0000950170-24-127644-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024127644/crbp-20241115.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T23:46:44.157517+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}